189 related articles for article (PubMed ID: 29328475)
1. Heat shock protein 27 knockdown using nucleotide‑based therapies enhances sensitivity to 5-FU chemotherapy in SW480 human colon cancer cells.
Shimada T; Tsuruta M; Hasegawa H; Okabayashi K; Shigeta K; Ishida T; Asada Y; Suzumura H; Koishikawa K; Akimoto S; Kitagawa Y
Oncol Rep; 2018 Mar; 39(3):1119-1124. PubMed ID: 29328475
[TBL] [Abstract][Full Text] [Related]
2. A phase I dose-escalation study of apatorsen (OGX-427), an antisense inhibitor targeting heat shock protein 27 (Hsp27), in patients with castration-resistant prostate cancer and other advanced cancers.
Chi KN; Yu EY; Jacobs C; Bazov J; Kollmannsberger C; Higano CS; Mukherjee SD; Gleave ME; Stewart PS; Hotte SJ
Ann Oncol; 2016 Jun; 27(6):1116-1122. PubMed ID: 27022067
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-494 sensitizes colon cancer cells to fluorouracil through regulation of DPYD.
Chai J; Dong W; Xie C; Wang L; Han DL; Wang S; Guo HL; Zhang ZL
IUBMB Life; 2015 Mar; 67(3):191-201. PubMed ID: 25873402
[TBL] [Abstract][Full Text] [Related]
5. Suppression of heat shock protein 27 expression promotes 5-fluorouracil sensitivity in colon cancer cells in a xenograft model.
Hayashi R; Ishii Y; Ochiai H; Matsunaga A; Endo T; Hasegawa H; Kitagawa Y
Oncol Rep; 2012 Oct; 28(4):1269-74. PubMed ID: 22842517
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Heat-shock Protein 27 Reduces 5-Fluorouracil-acquired Resistance in Human Colon Cancer Cells.
Asada Y; Tsuruta M; Okabayashi K; Shigeta K; Ishida T; Shimada T; Suzumura H; Koishikawa K; Akimoto S; Hasegawa H; Kitagawa Y
Anticancer Res; 2021 Mar; 41(3):1283-1290. PubMed ID: 33788719
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-23a antisense enhances 5-fluorouracil chemosensitivity through APAF-1/caspase-9 apoptotic pathway in colorectal cancer cells.
Shang J; Yang F; Wang Y; Wang Y; Xue G; Mei Q; Wang F; Sun S
J Cell Biochem; 2014 Apr; 115(4):772-84. PubMed ID: 24249161
[TBL] [Abstract][Full Text] [Related]
8. microRNA-577 suppresses tumor growth and enhances chemosensitivity in colorectal cancer.
Jiang H; Ju H; Zhang L; Lu H; Jie K
J Biochem Mol Toxicol; 2017 Jun; 31(6):. PubMed ID: 28150434
[TBL] [Abstract][Full Text] [Related]
9. Acquired resistance to 5-fluorouracil via HSP90/Src-mediated increase in thymidylate synthase expression in colon cancer.
Ahn JY; Lee JS; Min HY; Lee HY
Oncotarget; 2015 Oct; 6(32):32622-33. PubMed ID: 26416450
[TBL] [Abstract][Full Text] [Related]
10. Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein.
He WT; Zhu YH; Zhang T; Abulimiti P; Zeng FY; Zhang LP; Luo LJ; Xie XM; Zhang HL
Chin J Integr Med; 2019 Jun; 25(6):416-424. PubMed ID: 30484020
[TBL] [Abstract][Full Text] [Related]
11. Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells.
Kamada M; So A; Muramaki M; Rocchi P; Beraldi E; Gleave M
Mol Cancer Ther; 2007 Jan; 6(1):299-308. PubMed ID: 17218637
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
13. A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer.
Yu EY; Ellard SL; Hotte SJ; Gingerich JR; Joshua AM; Gleave ME; Chi KN
Invest New Drugs; 2018 Apr; 36(2):278-287. PubMed ID: 29250742
[TBL] [Abstract][Full Text] [Related]
14. MiR-214 sensitizes human colon cancer cells to 5-FU by targeting Hsp27.
Yang Y; Bao Y; Yang GK; Wan J; Du LJ; Ma ZH
Cell Mol Biol Lett; 2019; 24():22. PubMed ID: 30915129
[TBL] [Abstract][Full Text] [Related]
15. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
16. Hsp27 Inhibition with OGX-427 Sensitizes Non-Small Cell Lung Cancer Cells to Erlotinib and Chemotherapy.
Lelj-Garolla B; Kumano M; Beraldi E; Nappi L; Rocchi P; Ionescu DN; Fazli L; Zoubeidi A; Gleave ME
Mol Cancer Ther; 2015 May; 14(5):1107-16. PubMed ID: 25740245
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Hsp27 and Hsp40 potentiates 5-fluorouracil and carboplatin mediated cell killing in hepatoma cells.
Sharma A; Upadhyay AK; Bhat MK
Cancer Biol Ther; 2009 Nov; 8(22):2106-13. PubMed ID: 19901540
[TBL] [Abstract][Full Text] [Related]
18. Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer.
Bellmunt J; Eigl BJ; Senkus E; Loriot Y; Twardowski P; Castellano D; Blais N; Sridhar SS; Sternberg CN; Retz M; Pal S; Blumenstein B; Jacobs C; Stewart PS; Petrylak DP
Ann Oncol; 2017 Oct; 28(10):2481-2488. PubMed ID: 28961845
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells.
Yang C; Pan Y; Deng SP
BMC Mol Cell Biol; 2019 Apr; 20(1):9. PubMed ID: 31039730
[TBL] [Abstract][Full Text] [Related]
20. [Effects of selective cyclooxygenase-2 inhibitor NS-398 on 5-fluorouracil chemotherapy and progression of colon cells: an experimental study].
Zhang YC; Wang S; Zhang H; Ye YJ; Liang B; Cui ZR
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):583-6. PubMed ID: 15144595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
